US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

248.72

-0.9300-0.37%

Post-market: 250.001.28+0.51%19:59 EDT

Volume:344.92K

Turnover:86.47M

Market Cap:565.71M

PE:- -

High:259.39

Open:256.76

Low:244.53

Close:249.65

52wk High:341.93

52wk Low:95.98

Shares:2.27M

Float Shares:2.27M

Volume Ratio:1.06

T/O Rate:15.16%

Dividend:0.90

Dividend Rate:0.36%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Owlet (OWLT) and Lifestance Health Group (LFST)

Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS

Sector Update: Healthcare Stocks Edge Higher Premarket Friday

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN) and Cullinan Management (CGEM)

Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and Nanobiotix (NBTX)

Health Care Select Sector SPDR: Pivot points

Rezolute: Buy Rating Reiterated as FDA Engagement and Strong HI Data Support Unchanged $6 Price Target

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)

Grail price target raised to $100 from $65 at Mizuho

Sunway Healthcare's Unit to Acquire Freehold Land in Related Party Deal

MT Newswires Live

Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Natera (NTRA) and Aveanna Healthcare Holdings (AVAH)

Analysts Are Bullish on These Healthcare Stocks: Lineage Therap (LCTX), Lyell Immunopharma (LYEL)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)

AstraZeneca Gets US FDA Priority Review for Investigative Bladder Cancer Therapy

MT Newswires Live

Xiayi Residents Urged to Check Expanded Social Insurance Subsidy Policy: Direct Payments to Individuals for Up to 12 Months

Memphasys Targets Potentially Faster US Regulatory Approval Pathway for Sperm Separation System

MT Newswires Live

Lanzhou to Stop Collecting Large Medical Insurance Premiums from Employers for Retirees Starting Next Year

Fisher & Paykel Healthcare Executive Adjusts Shareholding Through September Sale

Memphasys Maps Faster FDA Route for Felix IVF Device While Keeping Near-Term Focus Offshore

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/LABU/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":248.72,"timestamp":1790971200000,"preClose":249.65,"halted":0,"volume":344920,"hourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"delay":0,"changeRate":-0.003725215301422018,"floatShares":2274486,"shares":2274486,"eps":0,"marketStatus":"Market Closed","change":-0.93,"latestTime":"10-02 16:00:00 EDT","open":256.755,"high":259.39,"low":244.53,"amount":86471147.3688,"amplitude":0.059523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":249.65,"sharesOutstanding":3074486,"nav":248.875,"aum":566062383.8,"dividendRate":0.003633,"bidAskSpread":0.003777,"preHourTrading":{"tag":"盘前","latestPrice":256,"preClose":249.65,"latestTime":"09:27 EDT","volume":5553,"amount":1438964.4383999999,"timestamp":1790947678782,"change":6.35,"changeRate":0.025436,"amplitude":0.043381},"postHourTrading":{"tag":"盘后","latestPrice":250,"preClose":248.72,"latestTime":"19:59 EDT","volume":5030,"amount":1253587.6992,"timestamp":1790985599756,"change":1.28,"changeRate":0.005146,"amplitude":0.005179},"volumeRatio":1.05546,"impliedVol":0.9378,"impliedVolPercentile":0.5618},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":2274486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.05546,"shares":2274486,"dividePrice":0.9037,"high":259.39,"amplitude":0.059523,"preClose":249.65,"low":244.53,"week52Low":95.98,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":248.72,"eps":0,"divideRate":0.003633,"volume":344920,"delay":0,"ttmEps":0,"open":256.755,"prevYearClose":159.39,"prevWeekClose":252.47,"prevMonthClose":265.79,"prevQuarterClose":265.79,"fiveDayClose":252.47,"twentyDayClose":305.86,"sixtyDayClose":324.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2670642304","title":"Analysts Offer Insights on Healthcare Companies: Owlet (OWLT) and Lifestance Health Group (LFST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670642304","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670642304?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:30","pubTimestamp":1790346658,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Owlet (OWLT) and Lifestance Health Group (LFST) with...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-owlet-owlt-and-lifestance-health-group-lfst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-owlet-owlt-and-lifestance-health-group-lfst-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4581","FMED","BK4588","BK4539","BK4196","LU0029874061.USD","LU0128526141.USD","OWLT","XBI","XLV","BK4585","LFST","BK4535","LABU","BK4137","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423946","title":"Pharming announces U.S. FDA acceptance and Priority Review of sNDA for lower doses of Joenja® to treat children with APDS","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423946","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423946?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:30","pubTimestamp":1790346600,"startTime":"0","endTime":"0","summary":"If approved, Joenja would be available to eligible patients aged 4 years and older with APDS who weigh 13 kg or moreDecision follows recent approval of Joenja for children aged 4 to 11 years with APDS","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/25/3369191/0/en/pharming-announces-u-s-fda-acceptance-and-priority-review-of-snda-for-lower-doses-of-joenja-to-treat-children-with-apds.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440027","title":"Sector Update: Healthcare Stocks Edge Higher Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440027","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440027?lang=en_us&edition=fundamental","pubTime":"2026-09-25 21:19","pubTimestamp":1790342373,"startTime":"0","endTime":"0","summary":"Healthcare stocks were edging higher premarket Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.5%.STAAR Surgical (","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFSS7M15.SGD","LU2361044949.HKD","LU2271345857.HKD","IE0004445239.USD","LU2896262040.SGD","LU1280957306.USD","SG9999013999.USD","LU0820561909.HKD","ELIL","IE00BN29S564.USD","IE00BFTCPJ56.SGD","LLYZ","IE0002141913.USD","MHIP","TMED","MEDX","LU0096364046.USD","LU2087625088.SGD","CURE","LU0345770308.USD","SG9999001176.SGD","LU2552382215.SGD","LU0210536198.USD","LU2602419157.SGD","STAA","IE00BJJMRY28.SGD","IHE","LU0417517546.SGD","IE00B7KXQ091.USD","LU0354030511.USD","LU0097036916.USD","FTXH","LU1720051108.HKD","LU0158827948.USD","BK4548","GDOC","XLV","IYH","FHLC","LU0456855351.SGD","LU0882574139.USD","VHT","LU1720051017.SGD","BK4534","LU1917777945.USD","LU0943347566.SGD","LU2237443978.SGD","LU2237443465.HKD","LU2552382132.HKD","SG9999018857.SGD","LU0174119429.USD","IE00BJT1NW94.SGD","LU2112291526.USD","BK4599","LU1988902786.USD","LU0094547139.USD","LU2023250330.USD","HRTS","LU2468319806.SGD","LU2168564065.EUR","LU0787776722.HKD","LU0882574055.USD","LU1023059063.AUD","LU1061106388.HKD","LU2361045086.USD","SG9999015986.USD","LU0109391861.USD","LU2168563687.JPY","LU0006306889.USD","LU2211815571.USD","LU1232071149.USD","LU0353189680.USD","LU0471298777.SGD","FATE","LU2089284900.SGD","IE00BJLML261.HKD","LU0203201768.USD","LLII","LU0385154629.USD","IE0004445015.USD","LU1623119135.USD","LU2023251221.USD","SG9999014914.USD","LU2417539215.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0708995401.HKD","LU0466842654.USD","BK4139","BK4533","LU2023250504.SGD","LU0689472784.USD","IE00B2B36J28.USD","IE0005OL40V9.USD","SG9999015945.SGD","LU0079474960.USD","IE00B1BXHZ80.USD","LU1814569148.SGD","LU2491050071.SGD","BK4007","LU2237443895.HKD","IE00B1XK9C88.USD","SG9999014906.USD","LU2360106947.USD","AGNG","LU2361044865.SGD","SG9999015952.SGD","LU1323610961.USD","LU2491049909.HKD","LLYX","LU1064131342.USD","LU0316494557.USD","LU2108987350.USD","LU2471134879.HKD","LU0158827781.USD","LU0256863902.USD","IE00BK4W5M84.HKD","LU0109394709.USD","LU0061475181.USD","LU0820561818.USD","IE00B775H168.HKD","LU0114720955.EUR","LU2756315318.SGD","BK4588","IE00BK4W5L77.USD","LU0823434740.USD","IE0001KFT4U8.USD","LU0323591593.USD","LU1035775433.USD","LU1989771016.USD","LU2324357040.USD","NKTR","LU2168564495.EUR","LU0823416689.USD","LU2471134952.CNY","LU2491050154.USD","LU0823434583.USD","LU1093756168.USD","LU1267930730.SGD","LU1551013425.SGD","LU2265009873.SGD","LU2264538146.SGD","IE00BJJMRZ35.SGD","LU0203202063.USD","LU2168564222.USD","LU2756315664.SGD","LU2552382058.USD","IE00BJJMRX11.SGD","LU2111349929.HKD","RXL","LU2089984988.USD","SGXZ99366536.SGD","SGXZ51526630.SGD","LU0889565916.HKD","LU1127390331.HKD","LU0320765992.SGD","SG9999017495.SGD","LU0471298694.HKD","SG9999014880.SGD","LU0432979614.USD","LU2237443549.SGD","LU1069344957.HKD","LU0353189763.USD","LLY","LU1974910355.USD","SGXZ81514606.USD","LU1629891620.HKD","SG9999015978.USD","LU1551013342.USD","LU2750360641.GBP","LU0234572021.USD","LU1868837136.USD","LU0266013472.USD","ELIS","BK4516","LU1979441026.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU2746668461.USD","LU0225283273.USD","LU2461242641.AUD","THNR","LU1057294990.SGD","LU2746668974.SGD","SGXZ57979304.SGD","LU0964807845.USD","IE00B4JS1V06.HKD","LU0058720904.USD","LU2063271972.USD","LU2028103732.USD","LU2750360997.AUD","LU2462591350.SGD","BK4585","LU0122379950.USD","PPH","CANC","LU0786609619.USD","LU2237443622.USD","JDOC","LU2471134523.USD","LU1691799644.USD","LU2237443382.USD","LU0256863811.USD","LU2168564149.EUR","TRUH","LU0672654240.SGD","LU1548497426.USD","LABU","SGXZ31699556.SGD","LU1868836757.USD","LU1712237335.SGD","LU0683600562.USD","LU2213496289.HKD","IE00BKDWB100.SGD","LU1868837300.USD","BK4581","ILDR","LU0320765059.SGD","PJP","LU2471134796.USD","LU0133085943.USD","LU0289739699.SGD","LU2462157665.USD","MEDI","SG9999018865.SGD","LU0820562030.AUD","LU2106854487.HKD","LU1145028129.USD","SG9999014898.SGD","LU0238689110.USD","LU2357305700.SGD","IE00BKPKM429.USD","IBB","IE00BWXC8680.SGD","LU2089283258.USD","LU1093756325.SGD","LU2236285917.USD","SG9999001176.USD","LU1983299246.USD","IE00BFSS8Q28.SGD","LU1868836591.USD","BK4198","WDNA","LU1291159041.SGD","LU1868836914.USD","XBI","LU2237438978.USD","OZEM","LU0198837287.USD","LU0640476718.USD","IE0009355771.USD","IXJ","LU2456880835.USD","LU0354030438.USD","LU0106261372.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440157","title":"Analysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN) and Cullinan Management (CGEM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440157","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440157?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:50","pubTimestamp":1790340613,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on AMN Healthcare Services (AMN) and Cullinan Managemen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-amn-healthcare-services-amn-and-cullinan-management-cgem-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4588","BK4139","BK4196","XLV","AMN","LABU","BK4581","CGEM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440538","title":"Analysts Offer Insights on Healthcare Companies: Damora Therapeutics (DMRA) and Nanobiotix (NBTX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440538?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:30","pubTimestamp":1790339445,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Damora Therapeutics (DMRA) and Nanobiotix (NBTX) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-damora-therapeutics-dmra-and-nanobiotix-nbtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-damora-therapeutics-dmra-and-nanobiotix-nbtx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","XLV","BK4139","BK4539","BK4137","BK4581","BK4585","BK4588","HCSG","LABU","LENZ","LU0128526141.USD","NBTX","XBI","LU0029874061.USD","DMRA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670440589","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2670440589","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670440589?lang=en_us&edition=fundamental","pubTime":"2026-09-25 20:26","pubTimestamp":1790339175,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $172.11, Pivot Low: $169.30. These were calculated usi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-150?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-150?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LABU","XBI","BK4588","BK4581","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670744763","title":"Rezolute: Buy Rating Reiterated as FDA Engagement and Strong HI Data Support Unchanged $6 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2670744763","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670744763?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:55","pubTimestamp":1790337320,"startTime":"0","endTime":"0","summary":"Rezolute, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Yun Zhong from Wedbush maintained a Buy rating on th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reiterated-as-fda-engagement-and-strong-hi-data-support-unchanged-6-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/rezolute-buy-rating-reiterated-as-fda-engagement-and-strong-hi-data-support-unchanged-6-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670476954","title":"Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670476954","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670476954?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:40","pubTimestamp":1790336408,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on RegenXBio (RGNX) and Resmed (RMD). RegenXBio (RGNX...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-resmed-rmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regenxbio-rgnx-and-resmed-rmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4137","LU2008162690.USD","LABU","LU2177674079.SGD","BK4139","BK4581","IE00B5TLWC47.USD","RMD","BK4567","BK4504","BK4505","BK4548","XBI","LU0128526141.USD","BK4588","LU0170899867.USD","BK4585","LU0029874061.USD","BK4563","LGHT","RGNX","HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442202","title":"Grail price target raised to $100 from $65 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442202?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:36","pubTimestamp":1790336163,"startTime":"0","endTime":"0","summary":"Mizuho raised the firm’s price target on Grail (GRAL) to $100 from $65 and keeps a Neutral rating on the shares. The FDA panel voted that Galleri i...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-100-from-65-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-price-target-raised-to-100-from-65-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","LABU","GRAL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423734","title":"Sunway Healthcare's Unit to Acquire Freehold Land in Related Party Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423734","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423734?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:04","pubTimestamp":1790334242,"startTime":"0","endTime":"0","summary":"Sunway Healthcare's  subsidiary Sunway Medical Centre has entered into a sale and purchase agreement with Sunway Sentral Seremban for the acquisition of freehold land in Bandar Seremban, Negeri Sembilan, for 10.8 million ringgit.The acquisition is a related party transaction, as Sunway Sentral Seremban is a 70%-owned subsidiary of Sunway City Sdn Bhd, which in turn is a wholly-owned subsidiary of Sunway , while Sunway City also holds a 69.4% equity interest in SHH.The SPA is conditional upon the issuance of an individual title to the land in the name of Sunway Sentral Seremban, with the condition precedent to be fulfilled within 18 months plus an automatic three-month extension.SMC undertakes to develop and operate a medical centre as the primary use of the land, with completion expected in the first quarter of 2028, subject to contractual and development risks.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCSG","BK4585","BK4588","XBI","XLV","LU0029874061.USD","BK4581","LU0128526141.USD","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670442580","title":"Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670442580","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670442580?lang=en_us&edition=fundamental","pubTime":"2026-09-25 19:04","pubTimestamp":1790334240,"startTime":"0","endTime":"0","summary":"Merck and Eisai have won U.S. Food and Drug Administration approval of the dual oral regimen of Merck's Welireg plus both companies' Lenvima in certain patients with the most common type of kidney cancer.The companies on Friday said the green light covers the combination in adults with advanced renal cell carcinoma with a clear cell component following a programmed death receptor-1 or programmed death-ligand 1 inhibitor.Welireg plus Lenvima is the first approved combination of a hypoxia-inducible factor-2 alpha inhibitor and a multi-targeted vascular endothelial growth factor receptor tyrosine kinase inhibitors for these patients, the companies said.Rahway, N.J., drugmaker Merck and Tokyo-based Eisai formed a collaboration in 2018 to jointly develop, manufacture and commercialize Lenvima, which Eisai discovered.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Merck, Eisai Get FDA OK of Welireg/Lenvima Combo in Kidney Cancer","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670449564","title":"Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Natera (NTRA) and Aveanna Healthcare Holdings (AVAH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670449564","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670449564?lang=en_us&edition=fundamental","pubTime":"2026-09-25 16:50","pubTimestamp":1790326207,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Ligand Pharma (LGND), Natera (NTRA) and Aveanna Heal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ligand-pharma-lgnd-natera-ntra-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ligand-pharma-lgnd-natera-ntra-and-aveanna-healthcare-holdings-avah-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","LU2065171402.SGD","XLV","LU2065171311.SGD","LU0053671581.USD","LU0106261612.USD","LGND","BK4588","AVAH","LABU","LU0566484027.USD","LU2065170008.USD","GNOM","LU0963586101.USD","XBI","BK4585","LU2264538146.SGD","HELX","BK4196","LU1064131342.USD","IE0009354923.USD","LU2065731478.USD","LU1988902786.USD","BK4007","LU2065169927.USD","LU1559883803.SGD","LU0345770993.USD","BK4539","LU0012050646.USD","BK4139","BK4581","NTRA","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670446715","title":"Analysts Are Bullish on These Healthcare Stocks: Lineage Therap (LCTX), Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670446715","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670446715?lang=en_us&edition=fundamental","pubTime":"2026-09-25 16:30","pubTimestamp":1790325050,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lineage Therap (LCTX), Lyell Immunopharma (LYEL) and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-lineage-therap-lctx-lyell-immunopharma-lyel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-lineage-therap-lctx-lyell-immunopharma-lyel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0029874061.USD","LU0128526141.USD","BK4581","BK4137","XLV","BK4585","BK4539","LCTX","LYEL","BK4505","BK4139","HCSG","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670466074","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Imunon (IMNN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670466074","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670466074?lang=en_us&edition=fundamental","pubTime":"2026-09-25 16:10","pubTimestamp":1790323817,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amgen (AMGN) and Imunon (IMNN). Amgen (AMGN) In a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-amgen-amgn-and-imunon-imnn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-amgen-amgn-and-imunon-imnn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","IBB","BK4533","PBE","IE00BFTCPJ56.SGD","LU0122379950.USD","LU2112291526.USD","LABU","BK4566","LU0289739699.SGD","IMNN","XLV","LU1571399168.USD","XBI","LU2468319806.SGD","LU2089984988.USD","LU0868494617.USD","BK4137","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1057294990.SGD","SG9999001440.SGD","BK4585","IE0002141913.USD","LU1061106388.HKD","BK4139","IE00B4R5TH58.HKD","IE0009355771.USD","LU0320765992.SGD","BK4534","LU2242646821.SGD","LU0058720904.USD","LU0029874061.USD","LU0889565916.HKD","AMGN","BIB","IE00BJT1NW94.SGD","BK4599","BBH","BK4588","LU1983299246.USD","LU2242652126.USD","BK4581","LU1023059063.AUD","LU0128526141.USD","TBXU","IBBQ","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670445225","title":"AstraZeneca Gets US FDA Priority Review for Investigative Bladder Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2670445225","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670445225?lang=en_us&edition=fundamental","pubTime":"2026-09-25 15:48","pubTimestamp":1790322524,"startTime":"0","endTime":"0","summary":"AstraZeneca  said Friday the US Food and Drug Administration granted priority review to its application for an Imfinzi combination therapy to treat muscle-invasive bladder cancer.The treatment is intended for patients who cannot or choose not to receive cisplatin-based chemotherapy.The submission is based on a phase 3 trial, which showed the perioperative therapy delivered event-free and overall survival improvements compared with bladder removal surgery with or without approved secondary treatments, the company said.AstraZeneca said the FDA is expected to make a regulatory decision in Q4.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","LU2237443895.HKD","LU2468319806.SGD","LU0310800379.SGD","LU2237443382.USD","AZNH","BK4585","LU2462157665.USD","LU0320765992.SGD","LU2236285917.USD","LU2237443978.SGD","LU0889565916.HKD","LU0432979614.USD","LU2237443622.USD","LU2089984988.USD","LU2237443465.HKD","AZN","LABU","LU2237443549.SGD","LU2456880835.USD","IE00B3T34201.USD","LU0128525929.USD","LU2417539215.USD","LU0058720904.USD","BK4588","LU0109394709.USD","BK4568","LU0289739699.SGD","BK4007","LU0029864427.USD","LU1267930573.SGD","LU0708994859.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133567294","title":"Xiayi Residents Urged to Check Expanded Social Insurance Subsidy Policy: Direct Payments to Individuals for Up to 12 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=1133567294","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133567294?lang=en_us&edition=fundamental","pubTime":"2026-09-25 14:10","pubTimestamp":1790316630,"startTime":"0","endTime":"0","summary":"Residents of Xiayi County should take note of the continuation and expansion of the social insurance subsidy policy, which provides direct payments to individuals for a maximum of 12 months.Who...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","XBI","BK4588","LABU","XLV","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670092414","title":"Memphasys Targets Potentially Faster US Regulatory Approval Pathway for Sperm Separation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2670092414","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670092414?lang=en_us&edition=fundamental","pubTime":"2026-09-25 10:46","pubTimestamp":1790304377,"startTime":"0","endTime":"0","summary":"Memphasys  said a reassessment of its US regulatory strategy for the Felix sperm separation system identified a potentially faster, cost effective, and more direct pathway toward US Food and Drug Administration  clearance, according to a Friday filing with the Australian bourse.The company, which was previously contemplating the more complex De Novo pathway for Felix, said it identified a medical device it believes may provide an appropriate predicate, potentially allowing the device  to pursue the FDA's more established 510 clearance pathway.Memphasys will now engage with the FDA to seek feedback on the proposed pathway before proceeding to a formal submission, it said.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","LABU","BK4588","MEM.AU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176342794","title":"Lanzhou to Stop Collecting Large Medical Insurance Premiums from Employers for Retirees Starting Next Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1176342794","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176342794?lang=en_us&edition=fundamental","pubTime":"2026-09-25 10:10","pubTimestamp":1790302225,"startTime":"0","endTime":"0","summary":"It was learned from the Lanzhou Municipal Medical Insurance Bureau on September 24 that starting from January 1, 2027, the employer contribution portion of the large medical insurance premium for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","XLV","BK4581","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670278411","title":"Fisher & Paykel Healthcare Executive Adjusts Shareholding Through September Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2670278411","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670278411?lang=en_us&edition=fundamental","pubTime":"2026-09-25 09:27","pubTimestamp":1790299666,"startTime":"0","endTime":"0","summary":"Fisher & Paykel Healthcare Corporation Limited ( ($NZ:FPH) ) just unveiled an update. Fisher & Paykel Healthcare has reported a change in the share...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-executive-adjusts-shareholding-through-september-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/fisher-paykel-healthcare-executive-adjusts-shareholding-through-september-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4581","BK4585","BK8004","FPH.NZ","BK4588","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670701419","title":"Memphasys Maps Faster FDA Route for Felix IVF Device While Keeping Near-Term Focus Offshore","url":"https://stock-news.laohu8.com/highlight/detail?id=2670701419","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670701419?lang=en_us&edition=fundamental","pubTime":"2026-09-25 08:21","pubTimestamp":1790295660,"startTime":"0","endTime":"0","summary":"Memphasys Ltd ( ($AU:MEM) ) has issued an update. Memphasys Limited has reassessed its U.S. regulatory approach for the Felix™ Sperm Separation Sys...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/memphasys-maps-faster-fda-route-for-felix-ivf-device-while-keeping-near-term-focus-offshore?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/memphasys-maps-faster-fda-route-for-felix-ivf-device-while-keeping-near-term-focus-offshore?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","MEM","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":12,"totalSize":396,"code":"91000000","status":"200"}]}}